Psychiatry and Neurology, Neurology · Yeagertown, PA
NPI
1144288721
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
310 South Main St
Yeagertown, PA, 17099
Phone (717) 242-6330
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
964 services
Medicare patients, 2024
197
Average age 74
Drug cost, 2024
$677K
5,367 prescriptions
Company payments, 2025
$1,465
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rasik B Parmar was code 99213 (office e&m - established), 314 times for 150 patients. In total Rasik B Parmar billed 964 services in 13 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 314 | 150 | $57.34 | $18K |
| 99212 Office E&M - Established | Office | 235 | 126 | $34.07 | $8,007 |
| 95885 Electrical Nerve Conductivity | Office | 104 | 48 | $41.18 | $4,283 |
| 95886 Electrical Nerve Conductivity | Office | 103 | 51 | $61.83 | $6,369 |
| 95910 Electrical Nerve Conductivity | Office | 83 | 70 | $108.94 | $9,042 |
| 95819 Neurologic | Office | 47 | 45 | $301.00 | $14K |
| 99204 Office E&M - New | Office | 40 | 40 | $103.42 | $4,137 |
| 95908 Electrical Nerve Conductivity | Office | 19 | 18 | $71.86 | $1,365 |
By year: 2022 $85K for 1,116 services; 2023 $89K for 1,060 services; 2024 $67K for 964 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rasik B Parmar prescribed most often to Medicare patients was Gabapentin, with 805 prescriptions and refills. In total Rasik B Parmar wrote 5,367 Medicare prescriptions that cost $677K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 805 | 1,250 | 128 | $10K |
| Donepezil Hcl Generic | 482 | 969 | 120 | $4,611 |
| Primidone Generic | 376 | 621 | 61 | $9,548 |
| Pregabalin Generic | 338 | 394 | 37 | $4,193 |
| Ropinirole Hcl Generic | 326 | 553 | 56 | $6,512 |
| Topiramate Generic | 287 | 464 | 45 | $2,960 |
| Lamotrigine Generic | 273 | 397 | 33 | $2,533 |
| Tizanidine Hcl Generic | 272 | 404 | 65 | $4,531 |
| Levetiracetam Generic | 199 | 267 | 32 | $3,538 |
| Memantine Hcl Generic | 178 | 278 | 36 | $3,664 |
| Duloxetine Hcl Generic | 172 | 381 | 45 | $2,495 |
| Rivastigmine Rivastigmine Tartrate | 135 | 205 | 20 | $5,963 |
| Meloxicam Generic | 134 | 169 | 29 | $665 |
| Baclofen Generic | 130 | 158 | 25 | $972 |
| Oxcarbazepine Generic | 124 | 211 | 27 | $4,305 |
Brand drugs: 144 claims; generic drugs: 5,198 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rasik B Parmar $1,465 ($1,465 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $341.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $341 |
| Lundbeck LLC | 9 | $272 |
| Neurocrine BioSciences, Inc. NBIX | 18 | $219 |
| Eisai Inc. 4523.T | 7 | $151 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $90.88 |
| Pfizer Inc. PFE | 4 | $82.05 |
| Lilly USA, LLC LLY | 5 | $76.81 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $65.98 |
| Axsome Therapeutics, Inc. AXSM | 2 | $43.14 |
| Averitas Pharma Inc. | 2 | $36.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.